On sep 20, 2017: litigation record received.Litigation alleges extreme pain, discomfort, soreness, malaise, swelling, loss of energy, immobilization, and both acute localized damage to tissue and/or bone surrounding the acetabulum and systemic injuries.Update ad 10 apr 2019: medical records received.After review of medical records, the patient was revised to address elevated serum metal ions and adverse tissue reaction.No revision notes and lab data provided.
|
Product complaint # (b)(4).Investigation summary = > the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa- (b)(4).Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|